An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022195
Company: HIKMA

Medication Guide

REMS

Summary Review

Products on NDA 022195

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	AA	Yes	No
MORPHINE SULFATE	MORPHINE SULFATE	20MG/5ML	SOLUTION;ORAL	Prescription	AA	Yes	No
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	AA	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022195

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/17/2008	ORIG-1	Approval	Type 7 - Drug Already Marketed without Approved NDA	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022195,022207lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022195s000, 022207s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022195_022207_morphine_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022195s000_022207s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/15/2023	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022195Orig1s021ltr.pdf
07/22/2021	SUPPL-20	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022195Orig1s020ltr.pdf
03/04/2021	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022195Orig1s019ltr.pdf
10/07/2019	SUPPL-18	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022195s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022195Orig1s018ltr.pdf
09/18/2018	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022195s014s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022195Orig1s014s016ltr.pdf
09/18/2018	SUPPL-14	REMS - PROPOSAL - D-N-A	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022195s014s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022195Orig1s014s016ltr.pdf
12/16/2016	SUPPL-11	Labeling-Package Insert, Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022195s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022195Orig1s011ltr.pdf
06/02/2021	SUPPL-10	Efficacy-Pediatric	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022195Orig1s010, 022207Orig1s005ltr.pdf
01/09/2014	SUPPL-9	Labeling-Medication Guide	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022195Orig1s009ltr.pdf
04/18/2014	SUPPL-8	Manufacturing (CMC)		Label is not available on this site.
04/21/2015	SUPPL-7	Manufacturing (CMC)	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022195s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022195Orig1s007ltr.pdf
01/23/2012	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022195s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022195s006ltr.pdf
10/18/2011	SUPPL-5	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022195s005ltr.pdf
06/10/2011	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
01/25/2010	SUPPL-2	Efficacy-New Indication	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022195s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022195s002ltr.pdf

Labels for NDA 022195

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/15/2023	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022195s021lbl.pdf
07/22/2021	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s020lbl.pdf
06/02/2021	SUPPL-10	Efficacy-Pediatric	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s010lbl.pdf
03/04/2021	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s019lbl.pdf
10/07/2019	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022195s018lbl.pdf
10/07/2019	SUPPL-18	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022195s018lbl.pdf
09/18/2018	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022195s014s016lbl.pdf
09/18/2018	SUPPL-14	REMS - PROPOSAL - D-N-A	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022195s014s016lbl.pdf
12/16/2016	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022195s011lbl.pdf
12/16/2016	SUPPL-11	Labeling-Medication Guide	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022195s011lbl.pdf
12/16/2016	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022195s011lbl.pdf
04/21/2015	SUPPL-7	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022195s007lbl.pdf
01/23/2012	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022195s006lbl.pdf
01/25/2010	SUPPL-2	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022195s002lbl.pdf
03/17/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022195,022207lbl.pdf

Therapeutic Equivalents for NDA 022195

MORPHINE SULFATE

SOLUTION;ORAL; 10MG/5ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	Yes	AA	022195	HIKMA
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	No	AA	206573	PHARM ASSOC
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	No	AA	206308	RHODES PHARMS
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	No	AA	203518	TRIS PHARMA INC
MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION;ORAL	Prescription	No	AA	211454	WINDER LABS LLC

SOLUTION;ORAL; 20MG/5ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MORPHINE SULFATE	MORPHINE SULFATE	20MG/5ML	SOLUTION;ORAL	Prescription	Yes	AA	022195	HIKMA
MORPHINE SULFATE	MORPHINE SULFATE	20MG/5ML	SOLUTION;ORAL	Prescription	No	AA	206420	RHODES PHARMS
MORPHINE SULFATE	MORPHINE SULFATE	20MG/5ML	SOLUTION;ORAL	Prescription	No	AA	211454	WINDER LABS LLC

SOLUTION;ORAL; 100MG/5ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	Yes	AA	022195	HIKMA
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	201574	PADAGIS US
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	206573	PHARM ASSOC
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	206308	RHODES PHARMS
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	202348	SPECGX LLC
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	203518	TRIS PHARMA INC
MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION;ORAL	Prescription	No	AA	211454	WINDER LABS LLC

Top